In a small study, patients with GCA maintained remission after receiving three days of treatment with methylprednisolone followed by tocilizumab. [Read More]
Latest News
Janus Kinase Inhibitors Promising for Difficult-to-Treat RA
AbbVie, Lilly Face New Delays in FDA Approval for Expanded Use of Janus Kinase Inhibitors
CDC Advisers Consider Boosters for Immune-Compromised Americans
Will an App to Monitor Patient Outcomes Improve RA Disease Activity?
2022 Physician Fee Schedule Proposed Rule Released
In the proposed rule released July 13, the ACR is encouraged by the continued implementation of evaluation and management reimbursement adjustments to better reflect the work and expertise needed to treat complex patient populations, the extension of many telehealth flexibilities and the inclusion of the ACR’s proposed MACRA MIPS Value Pathway for rheumatology. [Read More]
